Filtered By:
Condition: Hemorrhagic Stroke
Infectious Disease: Coronavirus
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 369 results found since Jan 2013.
The Challenge of Managing Parkinson ' s Disease Patients during the COVID-19 Pandemic
Divyani Garg, Rajinder K. DhamijaAnnals of Indian Academy of Neurology 2020 23(7):24-27The 2019 novel coronavirus (nCoV) pandemic is rapidly developing across the globe and new information is emerging expeditiously and constantly, particularly in relation to neurological illnesses. Both central and peripheral nervous system involvement has been reported including headache, dizziness, hyposmia/anosmia, taste disturbances, seizures, stroke, alteration of the sensorium, and even acute hemorrhagic necrotizing leukoencephalopathy. Varying degrees of olfactory disturbances may pre-empt the diagnosis of COVID-19. Although no dire...
Source: Annals of Indian Academy of Neurology - April 23, 2020 Category: Neurology Authors: Divyani Garg Rajinder K. Dhamija Source Type: research
Neurological complications of coronavirus and COVID-19.
CONCLUSIONS: Future epidemiological studies and case records should elucidate the real incidence of these neurological complications, their pathogenic mechanisms and their therapeutic options.
PMID: 32329044 [PubMed - in process]
Source: Revista de Neurologia - April 26, 2020 Category: Neurology Authors: Carod-Artal FJ Tags: Rev Neurol Source Type: research
The challenge of managing parkinson & #39;s disease patients during the COVID-19 pandemic
Divyani Garg, Rajinder K DhamijaAnnals of Indian Academy of Neurology 2020 23(7):24-27
The 2019 novel coronavirus (nCoV) pandemic is rapidly developing across the globe and new information is emerging expeditiously and constantly, particularly in relation to neurological illnesses. Both central and peripheral nervous system involvement has been reported including headache, dizziness, hyposmia/anosmia, taste disturbances, seizures, stroke, alteration of the sensorium, and even acute hemorrhagic necrotizing leukoencephalopathy. Varying degrees of olfactory disturbances may pre-empt the diagnosis of COVID-19. Although no dir...
Source: Annals of Indian Academy of Neurology - April 23, 2020 Category: Neurology Authors: Divyani Garg Rajinder K Dhamija Source Type: research
Tubuloreticular inclusions in COVID-19 –related collapsing glomerulopathy
A 79-year-old man of African ancestry, with a history of hemorrhagic stroke, monoclonal gammopathy of unknown significance, and stage 3 chronic kidney disease due to hypertension, was admitted to Bichat Hospital on day 1 after the first symptom of COVID-19 (fever). Severe acute respiratory syndrome coronavirus 2 polymerase chain reaction was positive on nasal swab. At admission, urinary dipstick was normal and plasma creatinine was 224 μmol/l. On day 4 plasma albumin was at 29 g/l and proteinuria was 11.4 g per gram of urinary creatinine (80% of albumin).
Source: Kidney International - April 26, 2020 Category: Urology & Nephrology Authors: Fran çois Gaillard, Sophie Ismael, Aurélie Sannier, Hassan Tarhini, Thomas Volpe, Clarisse Greze, Marie Christine Verpont, Ilyass Zouhry, Christophe Rioux, François-Xavier Lescure, David Buob, Eric Daugas Tags: Nephrology Image Source Type: research
A review of pathophysiology and neuropsychiatric manifestations of COVID-19
ConclusionThe neurological manifestations of the COVID-19 are varied and the data about this continue to evolve as the pandemic continues to progress.
Source: Journal of Neurology - June 2, 2020 Category: Neurology Source Type: research
Central Apnea in a COVID19 Pediatric Patient
We report a pediatric patient with COVID 19 associated encephalopathy characterized by focal seizures and central apnea.
Source: Pediatric Neurology - June 3, 2020 Category: Neurology Authors: Stephanie Enner, Sanaya Hormozdyaran, Robin Varughese, Jennifer Milillo, Ivan Pavkovic, Emma Laureta, James Schneider, Sanjeev Kothare Tags: Short Communication Source Type: research
Telestroke in the Time of COVID-19: The Mayo Clinic Experience
On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) a pandemic, and in the weeks following, public health organizations, medical associations, and governing bodies throughout the world recommended limiting contact with others to “flatten the curve” of COVID-19. Although both ischemic and hemorrhagic strokes have been reported with COVID-19, there has been anecdotal suggestion of an overall decrease in stroke admissions. To date, the effects of any pandemic on telestroke service lines have not been described.
Source: Mayo Clinic Proceedings - June 12, 2020 Category: Internal Medicine Authors: Josephine F. Huang, Melanie R.F. Greenway, Deena M. Nasr, Felix E. Chukwudelunzu, Bart M. Demaerschalk, Cumara B. O ’Carroll, Charisse A. Nord, Emily A. Pahl, Kevin M. Barrett, Lindsy N. Williams Tags: Brief Report Source Type: research
Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
AbstractRecently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described...
Source: Journal of Neurology - June 23, 2020 Category: Neurology Source Type: research
Central Apnea in an Adolescent With COVID-19
We describe a pediatric girl with COVID-19 –associated encephalopathy characterized by focal seizures and central apnea.
Source: Pediatric Neurology - June 3, 2020 Category: Neurology Authors: Stephanie Enner, Sanaya Hormozdyaran, Robin Varughese, Jennifer Milillo, Ivan Pavkovic, Emma Laureta, James Schneider, Sanjeev Kothare Tags: Clinical Letter Source Type: research
Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection
An increasing body of evidence suggests that the coronavirus disease 2019 (SARS-CoV2) may be associated with cerebrovascular disease, although most cases have been ischemic strokes related to occlusion of major intracranial vessels [1 –3]. Intracranial hemorrhages in the setting of SARS-CoV2 infection are exceedingly rare. To the best of our knowledge, only two cases has been reported in detail, one with a massive parenchymal brain hemorrhage and the other with an aneurysmal subarachnoid hemorrhage [4,5].
Source: Journal of the Neurological Sciences - July 14, 2020 Category: Neurology Authors: P.R. Castillo, O.H. Del Brutto, H. Mautong, M. Garc ía, M. Tovar, E.H. Middlebrooks, E. Bologna Tags: Letter to the Editor Source Type: research
Neurological complications of COVID-19: a systematic review.
CONCLUSIONS: Considering the possibility of neurological involvement in patients with SARS-CoV-2 infection can result in earlier diagnosis and treatment; otherwise permanent, irreversible sequelae and even death may follow. More comprehensive studies may indicate that until the end of the present pandemic, young adults with unexplained and unexpected stroke as well as patients with newly diagnosed Guillain-Barré syndrome should be tested for SARS-CoV-2 infection.
PMID: 32698732 [PubMed - as supplied by publisher]
Source: Neurological Research - July 25, 2020 Category: Neurology Tags: Neurol Res Source Type: research
Telestroke in the Time of COVID-19: The Mayo Clinic Experience
On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) a pandemic, and in the weeks following, public health organizations, medical associations, and governing bodies throughout the world recommended limiting contact with others to “flatten the curve” of COVID-19. Although both ischemic and hemorrhagic strokes have been reported with COVID-19, there has been anecdotal suggestion of an overall decrease in stroke admissions. To date, the effects of any pandemic on telestroke service lines have not been described.
Source: Mayo Clinic Proceedings - June 12, 2020 Category: Internal Medicine Authors: Josephine F. Huang, Melanie R.F. Greenway, Deena M. Nasr, Felix E. Chukwudelunzu, Bart M. Demaerschalk, Cumara B. O ’Carroll, Charisse A. Nord, Emily A. Pahl, Kevin M. Barrett, Lindsy N. Williams Tags: Brief report Source Type: research
Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
We appreciate Klein et al. [1] for reporting the case of cerebral venous thrombosis accompanied by hemorrhagic infarct in a young patient with novel coronavirus disease 2019 (COVID-19). The reporting of such a case would raise the awareness of the possibility of the occurrence of cerebral venous thrombosis in the course of COVID-19, especially among the young adults present with COVID-19 and neurological symptoms.
Source: Journal of Stroke and Cerebrovascular Diseases - August 2, 2020 Category: Neurology Authors: Chia Siang Kow, Abdullah Faiz Zaihan, Syed Shahzad Hasan Source Type: research
Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19
Covid-19 has significant implications of hematologic systems, including lymphocytopenia, thrombocytopenia, ischemic or hemorrhagic stroke, pulmonary thromboembolism, and myocardial infarction [1,2]. Iwasaki et al. reported that the pathogen of Covid-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can induce immune dysfunction, inflammation, and antibody-dependent enhancement by activating host cells via the Fc γIIa receptor in the same way as SARS-CoV-1 [3].
Source: Thrombosis Research - August 2, 2020 Category: Hematology Authors: Ching-Tai Huang, Shao-Yun Hsu, Ko-Wei Chang, Chung-Guei Huang, Cheng-Ta Yang, Ming-Huei Cheng Tags: Letter to the Editors-in-Chief Source Type: research
Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19
ConclusionsThe COVID-19 pandemic was associated with a significant decrease in all-cause admission and admissions due to cardiovascular events in the emergency department. Regarding acute cerebrovascular events there was a numerical decrease but no significant difference.
Source: Clinical Research in Cardiology - August 3, 2020 Category: Cardiology Source Type: research
